Verrucous leukoplakia of the red border caused by the use of IQOS heated tobacco product (a case report)
Keywords:verrucous leukoplakia, precancerous conditions, IQOS, HEETS
The aim. To analyze possibility of development and describe the clinical case of the red border verrucous leukoplakia caused by the use of IQOS heated tobacco product and HEETS sticks and propose personalized clinical, diagnostic and therapeutic algorithm of a patient management.
Materials and methods. Based on own observation, this article describes a clinical case of verrucous leukoplakia of the red border arising in a patient who used IQOS heated tobacco product and HEETS sticks. Clinical, laboratory, instrumental examination and treatment were performed on the basis of the Department of Dermatovenereology and Cosmetology with the course of Dermatovenereology and Aesthetic Medicine of the Postgraduate Education Faculty of Zaporizhzhia State Medical University.
Results. The plaque-type verrucous leukoplakia of the red border was diagnosed based on clinical examination of the patient and diagnosis verification by means of laboratory examination and dermatoscopy. Considering the possible traumatic lesion, a high probability of the disease recurrence, patient’s refusal of surgical treatment methods, the topical therapy for affected area with the use of combined drug containing glucocorticosteroid, antibacterial and antimycotic components was prescribed for 1 month followed by long-term therapy using 1 % pimecrolimus cream.
Conclusions. Based on the literature analysis, it was found out that IQOS heated tobacco product and HEETS sticks can promote the development of such manifestations of oxidative stress and endothelial dysfunction as inflammation, infection, fibrosis, oncologic pathology and become one of initiating agents for the occurrence of red border verrucous leukoplakia. The use of topical glucocorticosteroids combined with topical inhibitors of calcineurin can be proposed as an alternative to surgical methods of treatment for leukoplakia and it requires more detailed study.
Başaran, R., Güven, N. M., & Eke, B. C. (2019). An Overview of iQOS® as a New Heat-Not-Burn Tobacco Product and Its Potential Effects on Human Health and the Environment. Turkish Journal of Pharmaceutical Sciences, 16(3), 371-374. https://doi.org/10.4274/tjps.galenos.2018.79095
Glantz, S. A. (2018). Heated tobacco products: the example of IQOS. Tobacco Control, 27(Suppl. 1), s1-s6. https://doi.org/10.1136/tobaccocontrol-2018-054601
Cancelada, L., Sleiman, M., Tang, X., Russell, M. L., Montesinos, V. N., Litter, M. I., Gundel, L. A., & Destaillats, H. (2019). Heated Tobacco Products: Volatile Emissions and Their Predicted Impact on Indoor Air Quality. Environmental science & technology, 53(13), 7866-7876. https://doi.org/10.1021/acs.est.9b02544
Uchiyama, S., Noguchi, M., Takagi, N., Hayashida, H., Inaba, Y., Ogura, H., & Kunugita, N. (2018). Simple Determination of Gaseous and Particulate Compounds Generated from Heated Tobacco Products. Chemical Research in Toxicology, 31(7), 585-593. https://doi.org/10.1021/acs.chemrestox.8b00024
Davis, B., Williams, M., & Talbot, P. (2019). iQOS: evidence of pyrolysis and release of a toxicant from plastic. Tobacco Control, 28(1), 34-41. https://doi.org/10.1136/tobaccocontrol-2017-054104
Leigh, N. J., Tran, P. L., O'Connor, R. J., & Goniewicz, M. L. (2018). Cytotoxic effects of heated tobacco products (HTP) on human bronchial epithelial cells. Tobacco Control, 27(Suppl. 1), s26-s29. https://doi.org/10.1136/tobaccocontrol-2018-054317
Sohal, S. S., Eapen, M. S., Naidu, V., & Sharma, P. (2019). IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette. ERJ Open Research, 5(1), Article 00159-2018. https://doi.org/10.1183/23120541.00159-2018
Nabavizadeh, P., Liu, J., Havel, C. M., Ibrahim, S., Derakhshandeh, R., Jacob Iii, P., & Springer, M. L. (2018). Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke. Tobacco Control, 27(Suppl. 1), s13-s19. https://doi.org/10.1136/tobaccocontrol-2018-054325
Leigh, N. J., Palumbo, M. N., Marino, A. M., O'Connor, R. J., & Goniewicz, M. L. (2018). Tobacco-specific nitrosamines (TSNA) in heated tobacco product IQOS. Tobacco Control, 27(Suppl. 1), s37-s38. https://doi.org/10.1136/tobaccocontrol-2018-054318
Konstantinou, E., Fotopoulou, F., Drosos, A., Dimakopoulou, N., Zagoriti, Z., Niarchos, A., Makrynioti, D., Kouretas, D., Farsalinos, K., Lagoumintzis, G., & Poulas, K. (2018). Tobacco-specific nitrosamines: A literature review. Food and Chemical Toxicology, 118, 198-203. https://doi.org/10.1016/j.fct.2018.05.008
Brake, S. J., Barnsley, K., Lu, W., McAlinden, K. D., Eapen, M. S., & Sohal, S. S. (2020). Smoking Upregulates Angiotensin-Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). Journal of Clinical Medicine, 9(3), Article 841. https://doi.org/10.3390/jcm9030841
Maia, H. C., Pinto, N. A., Pereira, J., de Medeiros, A. M., da Silveira, É. J., & Miguel, M. C. (2016). Potentially malignant oral lesions: clinicopathological correlations. Einstein, 14(1), 35-40. https://doi.org/10.1590/S1679-45082016AO3578
Borysenko, A., & Kolenko, J. (2017). Sovremennyi podkhod k diagnostike leikoplakii slizistoi obolochki polosti rta [Modern approaches to diagnostics of oral leukoplakia]. Science yesterday, today, tomorrow: Proceedings of the XLIV International scientific-practical conference. (Issue 3, pp. 26-34). Izd. ANS «SibAK». [in Russian].
Syomkin, V. A., Rabinovich, O. F., Babichenko, I. I., & Bezrukov, A. A. (2017). Leikoplakiya: klinicheskii i patomorfologicheskii diagnoz [Leukoplakia: clinical and pathological diagnosis]. Stomatologiya, (1), 72-76. https://doi.org/10.17116/stomat201796172-76 [in Russian].
Kolenko, Yu. (2016). Rol chynnykiv ryzyku v rozvytku peredrakovykh zakhvoriuvan slyzovoi obolonky porozhnyny rota [Role of risk faktors for development of prcancerous diseases of the oral mucosa]. Sovremennaya stomatologiya, (1), 53-56. [in Ukrainian].
Irani, S. (2016). Pre-Cancerous Lesions in the Oral and Maxillofacial Region: A Literature Review with Special Focus on Etiopathogenesis. Iranian Journal of Pathology, 11(4), 303-322.
Mohammed, F., & Fairozekhan, A. T. (2020). Oral Leukoplakia. StatPearls [Internet]. StatPearls Publishing.
Speight, P. M., Khurram, S. A., & Kujan, O. (2018). Oral potentially malignant disorders: risk of progression to malignancy. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 125(6), 612-627. https://doi.org/10.1016/j.oooo.2017.12.011
Kostina, I. N., Epishova, A. A., Grigor'ev, S. S., Chernysheva, N. D., & Sorokoumova, D. V. (2019). Predrakovye zabolevaniya slizistoi obolochki polosti rta, krasnoi kaimy gub i kozhi litsa [Pre-cancer diseases of the mucous membrane of the oral cavity, red border of the lips and facial skin]. Izdatel'skii Dom «TIRAZh». [in Russian].
Syomkin, V. A., Rabinovich, O. F., Agapitova, L. P., Bezrukov, A. A., & Babichenko, I. I. (2018). Diagnosticheskaya tsennost' metoda kogerentnoi tomografii u bol'nykh s leikoplakiei slizistoi obolochki rta [Diagnostic value of optical coherence tomography for oral leukoplakia assessment]. Stomatologiya, (1), 37-39. https://doi.org/10.17116/stomat201897137-39 [in Russian].
Istomin, Yu. P., Artemyeva, T. P., & Tzerkovsky, D. A. (2016). Fotodinamicheskaya terapiya leikoplakii slizistoi obolochki polosti rta s fotosensibilizatorom fotolon [Photodynamic therapy with photosensitizer photolon for oral leukoplakia]. Biomedical Photonics, 5(2), 13-20. https://doi.org/10.24931/2413-9432-2016-5-2-13-20 [in Russian].
Chen, Q., Dan, H., Tang, F., Wang, J., Li, X., Cheng, J., Zhao, H., & Zeng, X. (2019). Photodynamic therapy guidelines for the management of oral leucoplakia. International Journal of Oral Science, 11(2), Article 14. https://doi.org/10.1038/s41368-019-0047-0
Bogomolov, A. Ye. (2018). Characteristic of nicotine delivery devices – electronic cigarettes – as a tool to fight against tobacco dependence. Zaporozhye medical journal, 20(2), 275-279. https://doi.org/10.14739/2310-1210.2018.2.125528
How to Cite
LicenseAuthors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)